Purpose To review the current therapeutic options for the management of diabetic
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …

Diabetic macular edema (DME) is the most common cause of vision loss in patients with
diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 …

Intravitreal antivascular endothelial growth factor (anti-VEGF) treatment has drastically
improved the visual and anatomical outcomes in patients with diabetic macular edema …

The ability of light to enact damage on the neurosensory retina and underlying structures
has been well understood for hundreds of years. While the eye has adapted several …

Purpose.: To compare modified Early Treatment Diabetic Retinopathy Study (mETDRS)
focal/grid laser photocoagulation with normal-density (ND-SDM) or high-density (HD-SDM) …

Purpose: The purpose of this study was to evaluate and compare microperimetry and fundus
autofluorescence (FAF) after subthreshold micropulse diode laser versus modified Early …

Purpose: To present the state-of-the-art of subthreshold diode laser micropulse
photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema …

Aim: The study was a prospective randomised controlled double-masked trial performed in
two centres to compare sub-threshold micropulse diode laser photocoagulation (MPDL) with …

Purpose.: Subthreshold retinal phototherapy demonstrated clinical efficacy for the treatment
of diabetic macular edema without visible signs of retinal damage. To assess the range of …

Purpose To determine the long-term safety of high-density subvisible diode micropulse
photocoagulation (810 nm), compare the clinical findings with computational modeling of …